GlassScriptPhysician profile
Dana Jo Walker
NPI 1669759965
$696.39
in general payments reported to CMS, 2019-2025
13 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $156 · 2024: $318 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $138.00 | 2023-2025 | Inspire |
| Novo Nordisk INC | $99.75 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $67.90 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.92 | 2024 | Ofev, Jardiance |
| Lilly USA, LLC | $60.09 | 2024 | Jardiance, Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $46.23 | 2024-2025 | Capvaxive, Gardasil 9, Rotateq |
| Astrazeneca Pharmaceuticals LP | $43.21 | 2024-2025 | Breztri |
| Eisai INC. | $38.38 | 2024 | |
| Glaxosmithkline, LLC. | $34.93 | 2023 | |
| Phathom Pharmaceuticals, INC. | $33.07 | 2024-2025 | Voquezna |
| Pfizer INC. | $30.16 | 2025 | |
| Abbvie INC. | $26.30 | 2024 | |
| Ascensia Diabetes Care US INC. | $14.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.